GENELUX CORPORATION Comprehensive Income
GENELUX CORPORATION (GNLX) reported Comprehensive Income of -$9.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-13
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$9.47M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$8.94M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$9.25M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.95M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$32.20M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$29.82M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$28.29M.
- GENELUX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$5.21M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.47M 10-Q · filed 2026-08-13 | -$18.41M 10-Q · filed 2026-08-13 | -$27.66M derived: sum of 3 quarters · filed 2026-08-13 | -$35.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$8.94M 10-Q · filed 2026-05-07 | -$18.19M derived: sum of 2 quarters · filed 2026-05-07 | -$26.13M derived: sum of 3 quarters · filed 2026-05-07 | -$33.62M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$9.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$17.19M derived: sum of 2 quarters · filed 2026-03-19 | -$24.67M derived: sum of 3 quarters · filed 2026-08-13 | -$32.20M 10-K · filed 2026-03-19 |
| 2025-09-30 | -$7.95M 10-Q · filed 2025-11-05 | -$15.43M derived: sum of 2 quarters · filed 2026-08-13 | -$22.95M 10-Q · filed 2025-11-05 | -$31.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$7.48M 10-Q · filed 2026-08-13 | -$15.01M 10-Q · filed 2026-08-13 | -$24.05M derived: sum of 3 quarters · filed 2026-08-13 | -$30.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$7.53M 10-Q · filed 2026-05-07 | -$16.56M derived: sum of 2 quarters · filed 2026-05-07 | -$22.89M derived: sum of 3 quarters · filed 2026-05-07 | -$29.48M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$15.37M derived: sum of 2 quarters · filed 2026-03-19 | -$21.95M derived: sum of 3 quarters · filed 2026-03-19 | -$29.82M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$6.33M 10-Q · filed 2025-11-05 | -$12.91M derived: sum of 2 quarters · filed 2025-11-05 | -$20.78M 10-Q · filed 2025-11-05 | -$27.54M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$6.58M 10-Q · filed 2025-08-07 | -$14.45M 10-Q · filed 2025-08-07 | -$21.21M derived: sum of 3 quarters · filed 2025-08-07 | -$26.55M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$7.87M 10-Q · filed 2025-05-06 | -$14.62M derived: sum of 2 quarters · filed 2025-05-06 | -$19.97M derived: sum of 3 quarters · filed 2025-05-06 | -$25.79M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$12.10M derived: sum of 2 quarters · filed 2025-03-28 | -$17.92M derived: sum of 3 quarters · filed 2025-03-28 | -$28.29M 10-K · filed 2025-03-28 |
| 2023-09-30 | -$5.34M 10-Q · filed 2024-11-14 | -$11.17M derived: sum of 2 quarters · filed 2024-11-14 | -$21.53M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$5.82M 10-Q · filed 2024-08-14 | -$16.18M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$10.36M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$5.21M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |